Glycemic index, extended bolusing, and diabetes education in insulin pump therapy (GLIDE: A pilot study)
File(s)dia.2019.0079(2).pdf (151.73 KB) GLIDE paper final.docx (50.79 KB)
Published version
Accepted version
Author(s)
Rilstone, Sian
Reddy, Monika
Oliver, Nick
Type
Journal Article
Abstract
Background: There is no published evidence on whether advanced bolus education affects outcomes in insulin pump-treated type 1 diabetes. We assess the feasibility of delivering a clinical education program on rates of digestion and bolusing, and to assess its preliminary impact.
Methods: An interactive education session on glycemic index (GI), extended bolusing, and superbolusing was developed and assessed in a nonrandomized single-arm study for 12 weeks. Insulin pump-treated participants with type 1 diabetes were recruited. Glucose outcomes were assessed by blinded continuous glucose monitoring after the consumption of high-fat and high-GI test meal. The primary outcome measure was 8-h glucose area under the curve (AUC) after high-fat meals, before and after intervention. Secondary outcomes included time spent in hypoglycemia, quality of life, treatment satisfaction, HbA1c, frequency of use of extended boluses, and postprandial AUC.
Results: Eleven participants completed the study [mean (SD) age 42.3 (12.8) years, baseline HbA1c 57.3 (10.0) mmol/mol, duration of diabetes 19.5 (9.9) years]. AUC for glucose after test meals did not differ significantly after education except for in the first 2 h after the high-GI meal [precourse 83.1 (0.23–88.9), postcourse 5.38 (−16.2 to 50.8)]. Percentage time spent in hypoglycemia (<3.9 and <3.3 mmol/L) fell at week 12 compared with baseline [5.8 (IQR 2.1–8.3) % to 4.3 (IQR 2.1–5.4) %, P = 0.013, and 2.9 (IQR 1.2–3.9) % to 1.6 (IQR 0.7–2.4) %, P = 0.029, respectively].
Conclusion: Delivering an education program to support advanced boluses is feasible and may reduce exposure to hypoglycemia. A further trial is required to confirm the findings.
Methods: An interactive education session on glycemic index (GI), extended bolusing, and superbolusing was developed and assessed in a nonrandomized single-arm study for 12 weeks. Insulin pump-treated participants with type 1 diabetes were recruited. Glucose outcomes were assessed by blinded continuous glucose monitoring after the consumption of high-fat and high-GI test meal. The primary outcome measure was 8-h glucose area under the curve (AUC) after high-fat meals, before and after intervention. Secondary outcomes included time spent in hypoglycemia, quality of life, treatment satisfaction, HbA1c, frequency of use of extended boluses, and postprandial AUC.
Results: Eleven participants completed the study [mean (SD) age 42.3 (12.8) years, baseline HbA1c 57.3 (10.0) mmol/mol, duration of diabetes 19.5 (9.9) years]. AUC for glucose after test meals did not differ significantly after education except for in the first 2 h after the high-GI meal [precourse 83.1 (0.23–88.9), postcourse 5.38 (−16.2 to 50.8)]. Percentage time spent in hypoglycemia (<3.9 and <3.3 mmol/L) fell at week 12 compared with baseline [5.8 (IQR 2.1–8.3) % to 4.3 (IQR 2.1–5.4) %, P = 0.013, and 2.9 (IQR 1.2–3.9) % to 1.6 (IQR 0.7–2.4) %, P = 0.029, respectively].
Conclusion: Delivering an education program to support advanced boluses is feasible and may reduce exposure to hypoglycemia. A further trial is required to confirm the findings.
Date Issued
2019-07-22
Date Acceptance
2019-05-01
Citation
Diabetes Technology and Therapeutics, 2019, 21 (8), pp.452-455
ISSN
1520-9156
Publisher
Mary Ann Liebert
Start Page
452
End Page
455
Journal / Book Title
Diabetes Technology and Therapeutics
Volume
21
Issue
8
Copyright Statement
Copyright © 2019, Mary Ann Liebert, Inc., publishers. Final publication is available from Mary Ann Liebert, Inc., publishers https://www.liebertpub.com/doi/10.1089/dia.2019.0079
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000469512700001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Endocrinology & Metabolism
Continuous subcutaneous insulin infusion
Type 1 diabetes
Extended bolus
Superbolus
Education
FAT
PROTEIN
Publication Status
Published
Date Publish Online
2019-05-29